Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes
- 30 April 2011
- journal article
- review article
- Published by Elsevier BV in Thrombosis Research
- Vol. 127 (4), 287-291
- https://doi.org/10.1016/j.thromres.2010.10.012
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusionsTransfusion, 2010
- Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageNew England Journal of Medicine, 2010
- The platelet as an immune cell—CD40 ligand and transfusion immunomodulationImmunologic Research, 2009
- Current concepts in platelet transfusionAsian Journal of Transfusion Science, 2009
- Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With CancerArchives of Internal Medicine, 2008
- Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cellsBlood, 2008
- Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challengeBlood, 2008
- Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injuryBlood, 2006
- A possible survival advantage in adults with acute leukemia receiving ABO‐identical platelet transfusionsAmerican Journal of Hematology, 1994
- The role of ABO matching in platelet transfusionEuropean Journal of Haematology, 1993